Invenomic Capital Management fully exited its position in Haemonetics Corporation (HAE 0.54%), according to a February 17, 2026, SEC filing, selling 498,317 shares previously worth $24.29 million.What happenedAccording to a February 17, 2026, SEC filing, Invenomic Capital Management sold its entire stake of 498,317 shares in Haemonetics Corporation. The net position change for the quarter was $24.29 million.What else to knowThe fund’s exit from Haemonetics Corporation reduced the position from 1.2% of 13F A ...